Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 2500.00 | 1067.09 | 5418.00 | 5222.50 | 1.0384 | 1.0332 |
MDA-MB-231 | Erlotinib | 1 | uM | 10 | 2500.00 | 1067.09 | 5241.00 | 5222.50 | 1.0040 | 1.0036 |
MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 2500.00 | 1067.09 | 5310.67 | 5222.50 | 1.0181 | 1.0156 |
MDA-MB-231 | Erlotinib | 10 | uM | 10 | 2500.00 | 1067.09 | 4730.67 | 5222.50 | 0.9058 | 0.9154 |
MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 2500.00 | 1067.09 | 3627.33 | 5222.50 | 0.6947 | 0.7059 |
MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 2500.00 | 1067.09 | 5389.00 | 5222.50 | 1.0335 | 1.0288 |
MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 2500.00 | 1067.09 | 5228.33 | 5222.50 | 1.0019 | 1.0018 |
MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 2500.00 | 1067.09 | 5278.00 | 5222.50 | 1.0105 | 1.0080 |
MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 2500.00 | 1067.09 | 5336.67 | 5222.50 | 1.0220 | 1.0190 |
MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 2500.00 | 1067.09 | 5412.00 | 5222.50 | 1.0368 | 1.0319 |
MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 2500.00 | 1067.09 | 5383.00 | 5222.50 | 1.0326 | 1.0277 |
MDA-MB-231 | Lapatinib | 1 | uM | 10 | 2500.00 | 1067.09 | 5093.67 | 5222.50 | 0.9762 | 0.9785 |
MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 2500.00 | 1067.09 | 5175.33 | 5222.50 | 0.9916 | 0.9927 |
MDA-MB-231 | Lapatinib | 10 | uM | 10 | 2500.00 | 1067.09 | 3912.33 | 5222.50 | 0.7479 | 0.7594 |
MDA-MB-231 | Omipalisib | 0.0016596 | uM | 10 | 2500.00 | 1067.09 | 3395.67 | 3708.67 | 0.8788 | 0.8066 |
MDA-MB-231 | Omipalisib | 0.0033113 | uM | 10 | 2500.00 | 1067.09 | 3280.00 | 3708.67 | 0.8494 | 0.7690 |
MDA-MB-231 | Omipalisib | 0.01 | uM | 10 | 2500.00 | 1067.09 | 2773.67 | 3708.67 | 0.6936 | 0.5321 |
MDA-MB-231 | Omipalisib | 0.031623 | uM | 10 | 2500.00 | 1067.09 | 2543.67 | 3708.67 | 0.6272 | 0.4386 |
MDA-MB-231 | Omipalisib | 0.1 | uM | 10 | 2500.00 | 1067.09 | 1978.00 | 3708.67 | 0.4971 | 0.2701 |
MDA-MB-231 | Omipalisib | 0.31623 | uM | 10 | 2500.00 | 1067.09 | 1724.00 | 3708.67 | 0.4549 | 0.2297 |
MDA-MB-231 | Omipalisib | 1 | uM | 10 | 2500.00 | 1067.09 | 1362.00 | 3708.67 | 0.3702 | 0.0939 |
MDA-MB-231 | Omipalisib | 3.1623 | uM | 10 | 2500.00 | 1067.09 | 1165.33 | 3708.67 | 0.3269 | 0.0217 |
MDA-MB-231 | Omipalisib | 10 | uM | 10 | 2500.00 | 1067.09 | 930.33 | 3708.67 | 0.2631 | -0.0977 |
MDA-MB-231 | Nilotinib | 0.0033113 | uM | 10 | 2500.00 | 1067.09 | 3721.00 | 3708.67 | 1.0022 | 0.9992 |
MDA-MB-231 | Nilotinib | 0.01 | uM | 10 | 2500.00 | 1067.09 | 3802.00 | 3708.67 | 1.0369 | 1.0547 |